• Journal of Periodontal and Implant Science
• /
• 제33권3호
• /
• pp.457-474
• /
• 2003

The ultimate objective of periodontal treatment is to get rid of an on-going periodontal disease and further regenerate the supporting tissue, which is already destroyed, functionally. Currently, the bone grafting operation using various kinds of bone grafting materials and the operation for induced regeneration of periodontal tissue using the blocking membrane are performed for regeneration of the destroyed periodontal tissue. However, there are respective limitations Galenical preparations, which are used for regeneration of periodontal of tissue, has less risk of rejective reaction or toxicity that may be incidental to degradation and their effect is sustainable. Thus, in case they are applicable to a clinic, they can he used economically. Chitosan has such compatibility, biological actions including antibacterial activity, acceleration of wound treatment, etc., and excellent mechanical characteristics, which has recently aroused more interest in it. Also, it has been reported that it promotes osteogenesis directly or indirectly by functioning as a matrix to promote migration and differentiation of a specific precussor cell (for example, osteoblast) and further inhibiting the function of such a cell as fibroblast to prevent osteogenesis. In this study, the pure chitosan solution, which was obtained by purifying chitosan, was used. However, since this chitosan is of a liquiform, it is difficult to sustain it in a defective region. It is, therefore, essential to use a carrier for delivering chitosan to, and sustaining it gradually in the defective region. In the calvarial defect model of the Sprague-Dawley rat, it is relatively easy to maintain a space. Therefore, in this study, the chitosan solution with which ACS was wetted was grafted onto the defective region, For an experimental model, a calvarial defect of rat m s selected, and a critical size of the defective region was a circular defect with a diameter of 8 mm. A group in which no treatment was conducted for the calvarial defect was set as a negative control group. Another group in which treatment was conducted with ACS only was set as a positive control group (ACS group). And another group in which treatment was conducted was conducted with by grafting the pure chitosan solution onto the defective region through ACS which was wetted with the chitosan solution was set an experimental group (Chitosan/ACS group). Chitosan was applied to the Sprague-Dawley rat's calvarial bone by applying ACS which was wetted with the chitosan solution, and each Sprague-Dawley rat was sacrificed respectively 2 weeks and 8 weeks after the operation for such application. Then, the treatment results were compared and observed histologically and his tometrically. Thereby, the following conclusions were obtained. 1. In the experimental group, a pattern was shown that from 2 weeks after the operation, vascular proliferation proceeded and osteogenesis proceeded through osteoblast infiltration, and at 8 week after the operation, ACS was almost absorbed, the amount of osteogensis was increased and many osteoid tissue layers were observed. 2. At 2 weeks after the operation, each amount of osteogenesis appeared to be 8.70.8 %, 13.62.3 % and 4.80.7 % respectively in the experimental group, the positive control group and the negative control group. Accordingly, it appeared to be higher in the Experimental group and the positive control group than in the negative control group, but there was no significant difference statistically (p<0.01). 3. At 8 weeks after the operation, each amount of osteogenesis appeared to be 62.26.1%, 17.42.5 % and 8.21.4 % respectively in the experimental group, the positive control group and the negative control group. Accordingly, it appeared to be substantially higher in the experimental group than in the positive control group and the negative control group, and there was a significant difference statistically (p<0.01). As a result of conducting the experiment, when ACS was used as a carrier for chitosan, chitosan showed effective osteogenesis in the perforated defective region of the Sprague-Dawley rat's calvarial bone.

• Restorative Dentistry and Endodontics
• /
• 제36권3호
• /
• pp.238-242
• /
• 2011

구개치은발육구는 상악 전치에 나타나는 이상 치근 형태의 하나로 구개측 결절부에서 구개치은발육구를 관찰하였으며, 이 구는 치근단을 향하여 여러 깊이와 길이로 연장될 수 있다. 구개치은발육구는 세정되기 어렵고 청결이 불가능하여, 치태와 치석 등이 축적되어 접합상피의 파괴를 일으키고 빠르게 골연하 결손부가 발생할 수 있다. 또한 이차적으로 치수 조직을 이환시켜 근관-치주 병소가 발생할 수 있다. 본 증례 보고는 구개치은발육구로인해 근관 문제까지 야기된 임상증례를 보고하고 근관치료와 함께 여러가지 재료를 이용한 구개치은발육구의 치료결과를 관찰함으로써 이러한 치료방법의 효용성을 평가하고자 하였다.

• 대한소아치과학회지
• /
• 제36권4호
• /
• pp.586-590
• /
• 2009

Leukocyte adhesion deficiency type I(LAD I)은 혈관 내피 세포에 백혈구가 부착하는 과정에 결함이 발생하여 혈관에서 감염부위로의 백혈구의 이주가 방해되어 발생하는 질환으로, 재발성 감염증과 백혈구 증가증을 보이는 희귀 질환이다. 피부와 점막의 괴사성 감염, 장내 패혈증, 제대염, 중이염, 뇌수막염 등의 임상 증상을 보이며, 이러한 환자들의 주요한 구강 내 증상은 심각한 치주 질환과 치조골 소실, 치주낭 형성, 유치열과 영구치열의 부분적 또는 전체적 조기 상실을 보인다. 본 증례는 심한 사춘기전 치주염 소견을 보이는 LAD type I환자로 국소적, 전신적 감염을 예방하기 위해 정기적인 치과 내원으로 치면 세균막 관리를 시행하였다. 감염 시 항생제 투여 및 세균 도말 검사를 시행하였다.

• Maxillofacial Plastic and Reconstructive Surgery
• /
• 제18권1호
• /
• pp.61-68
• /
• 1996

1. 첫 번째 증례에서 관상 절개를 이용한 부분골 절제술과 Le Fort씨 1급 골절단술을 시행한 결과, 골절단술을 시행한 부위에 원활한 골 치유가 일어났다. 2. 두 번째 증례에서 관상 절개를 이용하여 두개안면부에 광범위한 부분골 절제술을 시행하여 만족할만한 결과를 얻었으며, 병소 부위 말초 혈관 과다는 병소의 성장에 따른 생리적 변화로 추정된다.

• Journal of Oral Medicine and Pain
• /
• 제25권2호
• /
• pp.159-165
• /
• 2000

Subsequent to an allogenic stem cell transplantation(ASCT) on patients with hematologic malignancy(AML, ALL, CML, multiple myeloma, lymphoma etc.), chronic GVHD(graft versus host disease), which is an immunological reaction, occurs. With treatment results from patients who were diagnosed with ALL(acute lymphocytic leukemia), undergone BMT(bone marrow transplantation) and showed oral and skin lesions due to GVHD, treatment of oral manifestations of leukemia and its general management were studied. 90% of patients with chronic GVHD show change in the oral mucosa causing oral manifestations such as leukoplakia, lichenoid change of the oral mucosa, mucosal atrophy, erythema, ulceration and xerostomia. In treating GVHD, extensive systemic immunosuppression cause bacterial, viral, fungal infection that are fatal, and even if the treatment is successful, the patient is already in a severe immunosuppressed state. Therefore, localized target therapy is preferred. In another words, topical application(rinse, cream, ointment etc.) of cyclosporin and steroid in treating oral chronic GVHD is highly recommended, and the use of PUVA(Psoralen Ultraviolet A) and thalidomide is reported to be effective. In treating such diseases, dental treatment to control pain and prevent secondary infection of oral manifestations is very important. To those patients with systemic diseases who show limited effect by general dental treatment, non-invasive treatment such as the dental laser, in addition to the use of drugs, may be necessary to actively treat pain and help the healing process. For greater results, new effective methods are to be developed for treatment.

• 대한골관절종양학회지
• /
• 제18권2호
• /
• pp.78-82
• /
• 2012

목적: 고용량 인터페론-${\alpha}2b$를 이용한 악성흑색종의 면역요법은 외과적 절제술 후 현미경적 적이나 남아있는 종양의 재발을 막고 무병생존율과 전체 생존율을 높이는 것으로 알려져 있다. 저자 등은 악성 흑색종 환자군에서 외과적 절제술 후 고용량 인터페론-${\alpha}$ 면역요법을 시행한 그룹의 무병생존기간 및 전체 생존율 등을 비교 분석하여 면역요법의 치료결과를 예비 보고하고자 한다. 대상 및 방법: 2010년 2월부터 2012년 10월까지 본원에서 악성 흑색종으로 진단받고 외과적 수술 후 면역치료를 시행한 5명을 대상으로 분석 하였다. 병기는 AJCC 병기를 이용하여 판정하였으며 IIA 3예, IIB 1예, IV 1예로 나타났다. 추시기간은 최소 7개월에서 최대 32개월이었다. 면역 요법을 시행한 군에서는 먼저 유도요법으로 ${\alpha}2b$를 체표면적 당 20만 IU를 총 4주간 1주일에 5회 정주하였으며 이후 유지요법으로 체표면적당 10만 IU를 총 48주간 1주일에 3회 피하주사하였다. 이들 환자들에 대해 국소재발과 국소전이, 그리고 원격전이여부를 조사하였고 무병생존기간을 조사하였다. 결과: 인터페론-${\alpha}2b$ 면역요법을 시행한 환자군에서 추시 흉부 전산화 단층촬영 및 양전자 컴퓨터 단층촬영을 통한 평가 결과 현재까지 모두 국소 재발 및 국소전이 원격전이의 증거가 없는 것으로 나타났다. 결론: 고용량 인터페론-${\alpha}$ 면역요법 시행군에서 현재까지 종양의 국소 재발 및 전이를 막는 것으로 나타났으나 향후 궁극적인 생존율 및 무병생존율 향상이 달성되는가에 대해서는 추가적인 연구대상과 추적관찰이 필요하겠다.

• Radiation Oncology Journal
• /
• 제12권2호
• /
• pp.209-217
• /
• 1994

목적 : 1987년 7월부터 1992년 12월까지 가톨릭의과대학 부속 성모병원 치료방사선과에서 만성골수성백혈병으로 진단되어 동종골수이식을 위한 전신방사선치료를 받은 환자 22명을 대상으로 생존율 및 재발율에 영향을 미치는 요소들을 알아보기 위하여 후향분석을 시행하였다. 대상 및 방법 : 22명중 14명은 만성기였으며 8명은 이행기 혹은 급전기였고 진단 후 골수이식까지의 기간은 4-36개월 (중간값, 8개월)이었으며, 모든 환자들은 HLA 완전일치의 동종골수이식을 위한 전처치로 화학요법과 전신방사선조사가 시행되었다. 전신방사선조사는 6예에서는 1200cGy/6 fractions/3days, 16예에서는 1320cGy/8fractions/4days로 시행되었다. 화학요법은 8명에서는 cyclophosphamide(CTX), 5명에서는 CTX과 Daunorubicin, 그리고 9명에서는 CTX과 Adriamycin이 병용되었다. 또한 골수이식전 비장이 절제된 경우는 14예였고 6예에서는 비장에 방사선조사 (250-800 cGy/2-8fractions)가 시행되었으며 2예에서는 비장 방사선조사후 비장절제술이 시행되었다. 이식편대숙주병을 예방하기 위해 4명에서는 cyclosporine A가 단독투여되었고 18명에서는 methotrexate가 추가 투여되었다. 결과 : 전체환자의 4년 생존율은 $58.8\%$였고 22명중 8명이 재발되었으며 4년 무병생존율은 $41.2\%$였다. 생존율 및 재발율, 이식편대숙주병에 있어서 환자의 성별, 연령, 진단에서 골수이식까지의 기간, 골수이식 당시의 병기, 비장상태, 골수공여자와의 성별 혹은 혈액형 일치여부, 골수 공여자의 연령, 전처치 항암제의 종류, 방사선치료방법, 이식편대숙주병의 억제를 위한 화학요법의 방법 등이 어떤 영향을 미치는지 분석한 결과 골수이식당시의 병기만이 생존율에 유의한 차이를 보였다. 또한 이식편대숙주병과 재발율 사이에도 유의한 연관성을 보이지 않았다. 결론적으로 동종골수이식을 위한 전처치 및 면역억제방법에 따라 생존율 및 재발율이 크게 다르지 않았으며 HLA 일치 혈연자중 골수공여자가 있는 만성기의 만성골수성 백혈병 관자에서 동종골수이식을 위한 전처치로서 화학요법과 함께 전신방사선 분할조사는 중요한 역할을 담당함을 알 수 있었으나 보다 많은 환자를 대상으로 한 전향적 연구가 필요할 것으로 사료된다.

• 대한의료기공학회지
• /
• 제11권1호
• /
• pp.236-261
• /
• 2009

'Jeom-hyeol-gigong(點穴氣功)' gives a drill, Gi(氣) as a place to jam. This pathogen(邪氣) is removed. Given the low places and supplement it energy to flow up the well is the cure. This is an internal organ and muscular Gi allows a natural flow. Blood, one that moves and guides Gi is Gi I still feel that it makes any blood, making you feel good in life is flowing with vitality. Gi driving our whole body, while supplying vital energy and blood circulation, helping to defend the body is functioning. 'Jeom-hyeol-gigong' principle of Gi where the blockages to flow naturally energy is to let the flow. Aura of the voluntary and proactive action will be to have healthy bodies. Gi as a whole-body blood circulation leading to the cells in each tissue to supply energy and nutrients to every cell as the original principles of free activities that will maximize your life. Gi to prevent the three causes Internal causes: 5 greed and 7 emotions External causes: climate, food, pathogens, stress, etc. The internal nor the external causes: internal and external factors that cause the complex elements, incorrect position of the bone caused by an imbalance Heart disease will be police officers and raise their resistance to disease than the body, what jung-gi(正氣) have to develop. Beneficial to human body's resistance to raise the jung-gi people young-gi(營氣) and wi-gi(衛氣) should be enhanced. If the form is perfectly possible, Gi cycle itself should not have to breathe. Abdominal diagnosis 'bok-su-ap-an-beop(伏手壓按法)', 'sam-ji-tam-an-beop(三指探按法)' hands are like this, which outlined five viscera in order to understand the problem, the lower side of the clavicle (lung), the pit of stomach (Heart), both the lower ribs (liver), navel below (kidney) can be diagnosed at such areas. In each area of the skin, abdominal muscle tension, aching, or pressing a fuss about, beating the ruling of the state and the problem is a clue. And mo-hyeol(募穴) and certain Acupressure group, the chest, back, belly, so that scattered around each' book 'of the problem can be found. This is also the target of such a diagnosis, such as shape, color of skin, muscle Mostly the scope of the pitch in the cervical spine is broad across the hips. sugi(手氣) method that 'an method(按法) and 'ma method(摩法), bak method(拍法) is.

• 한국환경농학회:학술대회논문집
• /
• 한국환경농학회 2009년도 정기총회 및 국제심포지엄
• /
• pp.273-282
• /
• 2009

The transmissible spongiform encephalopathies (TSEs) disease group are fatal neurodegenerative disorders affecting a wide range of hosts. The group includes kuru and Creutzfeldt-Jakob disease (CJD) in humans, scrapie in sheep and goats and Bovine spongiform encephalopathy (BSE) in cattle. The exact nature of the infectious agent involved in the transmission of these diseases remains controversial. However, a central event in their pathogenesis is the accumulation in infected tissues of an abnormal form of a host-encoded protein, the prion protein (PrP). Whereas the normal cellular protein is fully sensitive to protease ($PrP^{sen}$), the disease-associated prion protein ($PrP^d$) is only partly degraded ($PrP^{res}$), its amino-terminal end being removed. BSE was first reported in the mid-80s in the UK. Ten years later, a new form of human prion disease, variant CJD (vCJD) developed in the wake of the BSE epidemic, and there is now strong scientific evidence that vCJD was initiated by the exposure of humans to BSE-infected tissues, thus indicating a zoonotic disease. However, the ban on the feeding of animal-derived proteins to ruminants, and the apparent lack of vertical transmission of BSE, have led to a decline in the incidence of the disease within cattle herd and therefore, an assumed decreased risk for human contacting vCJD. The origin of the original case(s) of BSE still remains an enigma even though three hypotheses have been raised. Hypotheses are i) sheep- or goat-derived scrapie-infected tissues included in meat and bone meal fed to cattle, ii) a previously undetected sporadic or genetic bovine TSE contaminating cattle feed or iii) originating from a human TSE through animal feed contaminated with human remains. A host cellular membrane protein ($PrP^C$), which is abundant in central nervous system tissue, appear to be conformationally altered in the diseased host into a prion protein ($PrP^{Sc}$). This $PrP^{Sc}$ is detergent insoluble and partially protease-resistant ($PrP^{res}$). The term $PrP^{res}$ is normally used to describe the protein detected after protease treatment, in techniques such as Western immunoblotting, and enzyme-linked immunosorbant assay using fresh/frozen tissue. Immunohistochemistry may performed with formalin-fixed tissues. Also, clinical signs of the BSE are one of the major diagnostic indicators. Recently, atypical forms (known as H- and L-type) of BSE have appeared in several European countries, Japan, Canada and the United States. An unusual case was also reported in a miniature zebu. The atypical BSE fall into two groups based on the relative molecular mass (Mm) of the unglycosylated $PrP^{res}$ band relative to that of classical BSE, one of the higher Mm (H-type) and the other lower (L-type). Both types have been detected worldwide as rare cases in older animals, at a low prevalence consistent with the possibility of sporadic forms of prion diseases in cattle. This raises the unwelcome possibility that vCJD could increase in the human population. Now, active surveillance program against BSE is going on in Korea. In regional veterinary service lab, ELISA is applied to screen the BSE in slaughter and confirmatory tests by Western immunoblotting and immunohistochemisty are carried out if there are positive or suspect in the screening test. Also, the ruminant feed ban is rigorously enforced. Removal of specified risk materials such as brain and spinal cord from cattle is mandatory process at slaughter to prevent the infected material from entering the human food chain.

• IMMUNE NETWORK
• /
• 제3권2호
• /
• pp.150-155
• /
• 2003

Background: We investigated the effect of donor marrow T cell depletion, administration of FK506, cyclosporin A (CSA), and 3-deazaadenosine (DZA) on graft versus host disease (GVHD) after allogeneic murine hematopoietic stem cell transplantation (HSCT). Methods: We used 4 to 6 week old Balb/c ($H-2^d$, recipient), and C3H/He ($H-2^k$, donor) mice. Total body irradiated recipients received $1{\times}10^7$ bone marrow cells (BM) and $0.5{\times}10^7$ splenocytes of donor under FK506 (36 mg/kg/day), CSA (5 mg/kg/day, 20 mg/kg/day), and DZA (45 mg/kg/day), which were injected intraperitoneally from day 1 to day 14 daily and then three times a week for another 2 weeks. To prevent the GVHD, irradiated Balb/c mice were transplanted with $1{\times}10^7$ rotor-off (R/O) cells of donor BM. The severity of GVHD was assessed daily by clinical scoring method. Results: All experimental groups were well grafted after HSCT. Mice in experimental group showed higher GVHD score and more rapid progression of GVHD than the mice with R/O cells (R/O group) (p<0.01). There were relatively low GVHD scores and slow progressions in FK506 and low dose CSAgroups than high dose CSA group (p<0.01). The survival was better in FK506 group than low dose CSA group. All mice treated with CSA died within 12 days after HSCT. The GVHD score in DZA group was low and slow in comparison with control group (p<0.05), but severity and progression were similar with low dose CSA group (p=0.11). All mice without immunosuppressive treatment died within 8 days, but all survived in R/O group (p<0.01). Survival in low dose CSA group was longer than in control group (p<0.05), but in high dose CSA group, survival was similar to control group. The survival benefit in DZA group was similar with low dose CSA group. FK506 group has the best survival benefit than other groups (p<0.01), comparable with R/O group (p=0.18), although probability of survival was 60%. Conclusion: We developed lethal GVHD model after allogeneic murine HSCT. In this model, immunosuppressive agents showed survival benefits in prevention of GVHD. DZA showed similar survival benefits to low dose CSA. We propose that DZA can be used as a new immunosuppressive agent to prevent GVHD after allogeneic HSCT.